Walgreens plays down Amazon pharmacy entry, but investors spooked
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq futures outperform after Nvidia puts AI fears to rest
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil gains as traders weigh prospects of easing Middle East supply disruptions
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Dollar General stock jumps on earnings beat and raised guidance
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
Guggenheim Remains Bullish on Amazon (AMZN) Following PillPack Acquisition
July 2, 2018 7:37 AM EDTGuggenheim reiterated a Buy rating and $1850.00 price target on Amazon.com (NASDAQ: AMZN) following the company's recent acquisition of PillPack. This drove a 5-10% correction in drug retail shares on the assumption that this would place incremental pressure on pricing and profitability.
Analyst John... More
Walgreens Boosts Alliance (WBA) PT Lowered to $68 at RBC Capital
June 29, 2018 8:02 AM EDTRBC Capital lowered its price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $68.00 (from $88.00) while maintaining an Outperform rating.
Analyst George Hill views the sharp downward move Thursday following Amazon's entry into the pharmacy space as an overreaction.
... MoreCVS Health (CVS) PT Lowered to $84 at RBC Capital on Amazon Effect
June 29, 2018 7:10 AM EDTRBC Capital lowered its price target on CVS Health (NYSE: CVS) to $84.00 (from $91.00) while maintaining an Outperform rating to reflect Amazon's entrance into the pharmacy space.
"We acknowledge that Amazon has disrupted industries in the past, but believe that the stickiness of payer/ pharmacy... More
Walgreens Boosts Alliance (WBA) PT Lowered to $64 at Evercore ISI; Today was a 'Complete Mess', But Maintaining OP Rating
June 28, 2018 11:51 AM EDTEvercore ISI lowered its price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $64.00 (from $74.00) while maintaining an Outperform rating.
Analyst Ross Muken commented, "What a complete mess today turned out to be (and here I was worried about balancing MCKs Analyst Day w/ WBAs report). While on the surface WBAs print... More
